## SW: Smurfit WestRock plc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.28 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($33.51)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Groupama Asset Managment Acquires 80,778 Shares of Smurfit Westrock PLC $SW**
- Source: MarketBeat | 20251129T123618 | Neutral | Relevance: 100%
- Groupama Asset Managment increased its stake in Smurfit Westrock PLC by 15.3% in Q2, acquiring an additional 80,778 shares to hold a total of 608,350 shares valued at approximately $26.25 million. Smurfit Westrock reported mixed Q3 results with revenue beating estimates but EPS missing, while also declaring a quarterly dividend of $0.4308 despite a high payout ratio. Analysts currently maintain a "Moderate Buy" rating with a consensus price target of $55.30 for the stock.

**2. Norges Bank Invests $749.74 Million in Smurfit Westrock PLC $SW**
- Source: MarketBeat | 20251130T122159 | Neutral | Relevance: 99%
- Norges Bank has significantly increased its stake in Smurfit Westrock PLC by purchasing 17,375,882 shares valued at approximately $749.74 million, representing about 3.33% ownership. This comes as Smurfit Westrock recently announced a quarterly dividend, despite missing its consensus EPS estimate but increasing revenue year-over-year. Institutional interest in Smurfit Westrock remains high, with several other major firms also making changes to their holdings, and analysts rating the stock a "Moderate Buy."

**3. De Lisle Partners LLP Has $5.91 Million Stock Holdings in Smurfit Westrock PLC $SW**
- Source: MarketBeat | 20251201T095953 | Neutral | Relevance: 96%
- De Lisle Partners LLP increased its stake in Smurfit Westrock PLC (NYSE:SW) by 9.6% to 137,000 shares, now valued at approximately $5.91 million. This comes as Smurfit Westrock reported Q2 adjusted earnings of $0.58 per share, missing consensus estimates but exceeding revenue expectations with $8.0 billion. The company declared a quarterly dividend of $0.4308, reflecting an annualized yield of 4.8%, while institutional investors hold 83.38% of the stock, with analysts maintaining a "Moderate Buy" rating and an average target price of $55.30.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Argus Research | $45 | $55 | -18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Argus Research | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-23.6%)
- Blackrock Inc.: 8.3% (+4.9%)
- Capital Research Glo: 5.3% (-0.5%)
- State Street Corpora: 4.6% (+14.6%)
- Nuveen, LLC: 4.5% (-0.6%)

### Key Risks

1. Long-term trend broken: trading 18.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +4.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.28 indicates undervaluation relative to growth. Forward P/E 10.7x attractive for 32% earnings growth. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.4B |
| Beta | 1.01 |
| 52W Range | $32.73 - $56.05 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.28 |
| Forward P/E | 10.7 |
| Current P/E | 14.2 |
| YoY Growth | 32.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -4.1% to 0.8% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 at 0.9% confirms short-term momentum alignment. Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 45.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.78% (CS: 60) | Neutral |
| RSI_14 | 44.8 | Neutral |
| MACD Histogram | 0.43 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 0.912x | Below |
| vs SMA200 | 0.820x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $35.65
- **Stop Loss:** $33.51 (6.0% risk)
- **Target:** $39.93 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 467
- **Position Value:** $16,648.55
- **Portfolio %:** 16.65%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-11 (Est: $0.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.72 | $0.58 | -19.8% |
| 2025Q2 | $0.59 | $0.51 | -13.9% |
| 2025Q1 | $0.67 | $0.83 | +24.2% |
| 2024Q4 | $0.59 | $0.42 | -28.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*